RT Journal Article
SR Electronic
T1 ‘Self-Management Intervention through Lifestyle Education for Kidney health’ (the SMILE-K study): protocol for a single-blind longitudinal randomised control trial with nested pilot study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.05.17.22275207
DO 10.1101/2022.05.17.22275207
A1 Lightfoot, Courtney J.
A1 Wilkinson, Thomas J.
A1 Yates, Thomas
A1 Davies, Melanie J
A1 Smith, Alice C.
YR 2022
UL http://medrxiv.org/content/early/2022/05/19/2022.05.17.22275207.abstract
AB Introduction Many people living with chronic kidney disease (CKD) are expected to self-manage their condition. Patient activation is the term given to describe the knowledge, skills, and confidence a person has in managing their own health and is closely related to the engagement in preventive health behaviors. Self-management interventions have the potential to improve remote disease management and health outcomes. We are testing an evidence- and theory-based digital self-management structured 10-week programme developed for CKD patients called ‘My Kidneys & Me’. The primary aim of the study (SMILE-K) is to assess the effect on patient activation levels.Methods and analysis A single-blind randomised control trial (RCT) with a nested pilot study will assess the feasibility of the intervention and study design before continuation to a full RCT. Individuals aged 18 years or older, with established CKD stage 3-4 (eGFR of 15-59 ml/min/1.73m2) will be recruited through both primary and secondary care pathways. Participants will be randomised into two groups: intervention group and control group. The primary outcome is the Patient Activation Measure (PAM-13). The full RCT will assess the effect of the programme on online self-reported outcomes which will be assessed at baseline, after 10-weeks, and then after 20-weeks in both groups. A total sample size of n=432 participants are required based on a 2:1 randomisation. A sub-study will measure physiological changes (e.g., muscle mass, physical function) and patient experience (qualitative semi-structured interviews).Ethics and dissemination This study was fully approved by the Research Ethics Committee-Leicester South on the 19/11/2020 (reference: 17/EM/0357). All participants are required to provide informed consent obtained online. The results are expected to be published in scientific journals and presented at clinical research conferences. This is protocol version 1.0 dated 27/01/2021.Trial registration number The study was prospectively registered as ISRCTN18314195 in December 2020.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialISRCTN18314195Funding StatementThis study is funded by the Stoneygate Trust and the Leicester NIHR Biomedical Research Centre. All PPIE activities were supported by two grants from the Leicester Kidney Care Appeal awarded to TJW and ACS. Funders had no input into study protocol.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was fully approved by the Research Ethics Committee-Leicester South on the 19/11/2020 (reference: 17/EM/0357). All participants are required to provide informed consent obtained online.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsBIABioelectrical Impendence AnalysisBMIBody Mass IndexCKDChronic Kidney DiseaseCKD-SMKTChronic Kidney Disease Self-Management Knowledge ToolCOVID-19Coronavirus Disease-2019DXADual-Energy X-Ray AbsorptiometryeGFREstimated Glomerular Filtration RateEPQModified Economic Patient QuestionnaireEWGSOPEuropean Working Group on Sarcopenia in Older PeopleGCPGood Clinical PracticeGPGeneral PractitionerGPPAQGeneral Practice Physical Activity QuestionnaireHGSHandgrip StrengthHRAHealth Research AuthorityIPQ-RIllness Representations QuestionnaireITTIntention-To-TreatKSQKidney Symptom QuestionnaireMARS-5Medication Adherence Report ScaleNHSNational Health ServiceNICENational Institute for Health and Care ExcellencePAIPhysical Activity IndexPAM-13Patient Activation MeasureQoLQuality of LifeRCTRandomised Control TrialRECResearch Ethics CommitteeSF-1212-Item Short Form Health SurveySPIRITStandard Protocol Items: Recommendations for Interventional TrialsSTSSit-To-StandTUAGTimed-Up-And-GoUKDDQUK Diabetes and Diet QuestionnaireUKRRUK Renal Registry